KOSDAQ - Delayed Quote KRW
Access Bio, Inc. (950130.KQ)
5,130.00
+80.00
+(1.58%)
At close: 3:30:30 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
112,462,797
112,462,797
348,643,147
1,033,863,094
505,111,695
Cost of Revenue
58,829,591
58,829,591
178,381,142
214,096,484
108,722,758
Gross Profit
53,633,206
53,633,206
170,262,005
819,766,610
396,388,937
Operating Expense
57,816,041
57,816,041
148,340,334
350,162,939
136,265,032
Operating Income
-4,182,835
-4,182,835
21,921,671
469,603,671
260,123,905
Net Non Operating Interest Income Expense
11,122,521
11,122,521
10,721,787
3,406,115
-3,137,698
Pretax Income
-143,862
-143,862
-5,879,346
463,696,166
256,760,216
Tax Provision
936,004
936,004
-580,477
113,950,620
66,683,149
Net Income Common Stockholders
-347,576
-347,576
-3,172,838
346,670,216
189,689,851
Basic EPS
-14.00
--
-91.00
10.05k
5.33k
Diluted EPS
-14.00
--
-91.00
9.21k
5.13k
Basic Average Shares
35,173.83
--
34,866.35
34,491.12
35,569.07
Diluted Average Shares
35,173.83
--
34,866.35
37,632.46
36,998.22
Total Operating Income as Reported
-4,230,062
-4,230,062
21,590,167
469,200,988
260,123,906
Rent Expense Supplemental
13,057
13,057
18,380
74,781
84,343
Total Expenses
116,645,632
116,645,632
326,721,476
564,259,423
244,987,790
Net Income from Continuing & Discontinued Operation
-347,576
-347,576
-3,172,838
346,670,216
189,689,851
Normalized Income
4,055,467.67
4,055,467.67
-1,657,131.60
353,459,156.75
188,392,056.43
Interest Income
14,592,537
14,592,537
14,432,501
5,709,896
211,982
Interest Expense
3,470,016
3,470,016
3,710,714
6,233,160
3,349,680
Net Interest Income
11,122,521
11,122,521
10,721,787
3,406,115
-3,137,698
EBIT
3,326,154
3,326,154
-2,168,632
469,929,326
260,109,896
EBITDA
23,403,893
23,403,893
13,791,210
480,755,822
266,174,328
Reconciled Cost of Revenue
58,829,591
58,829,591
178,381,142
214,096,484
108,722,758
Reconciled Depreciation
20,077,739
20,077,739
15,959,842
10,826,496
6,064,432
Net Income from Continuing Operation Net Minority Interest
-347,576
-347,576
-3,172,838
346,670,216
189,689,851
Total Unusual Items Excluding Goodwill
-5,573,473
-5,573,473
-1,681,748
-9,000,846
1,753,089
Total Unusual Items
-5,573,473
-5,573,473
-1,681,748
-9,000,846
1,753,089
Normalized EBITDA
28,977,366
28,977,366
15,472,958
489,756,668
264,421,239
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,170,429.33
-1,170,429.33
-166,041.60
-2,211,905.25
455,294.43
12/31/2021 - 5/30/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade